INIS
asia
54%
availability
8%
caucasus
50%
communities
50%
data
13%
diversification
6%
drugs
43%
females
8%
genes
9%
genetics
7%
hepatitis
75%
hiv
100%
humans
25%
kazakhstan
79%
kyrgyzstan
5%
length
6%
maximum-likelihood fit
6%
men
9%
mobility
12%
mutations
25%
origin
25%
patients
26%
people
33%
populations
13%
public health
5%
range
6%
reviews
31%
risks
54%
sex
13%
soviet union
25%
trade
6%
transmission
68%
travel
6%
tuberculosis
25%
uzbekistan
7%
viruses
52%
workers
8%
Keyphrases
Adverse Risk
5%
African Ancestry
12%
B Hepatitis
25%
Caucasus
25%
Central Asia
32%
Co-infection
7%
Cross-border Migrants
5%
Distinct Subtypes
6%
Drug-resistant Virus
5%
Effective Metric
8%
Env Gene
6%
Epidemiological Data
5%
Evolutionary Relationship
6%
Faculty Development
5%
Former Soviet Union
6%
Former Soviet Union Countries
18%
Free Mobility
8%
Gene Sequencing
5%
Genetic Similarity
6%
Grant Program
5%
HCV Infection
5%
Health Relevance
5%
Hepatitis B
25%
Hepatitis B Virus
25%
Hepatitis B Virus Infection
8%
Hepatitis C
25%
Heterosexual Men
5%
High-risk Community
25%
High-risk Population
10%
HIV Epidemic
21%
HIV Gene
5%
HIV Infection
7%
HIV Patients
25%
HIV Phylogenetics
5%
HIV Prevalence
7%
HIV Transmission
25%
HIV Variant
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
25%
Kazakhstan
50%
Maximum Likelihood
6%
Men Who Have Sex with Men
5%
Migrant Mobilities
8%
Mutation Analysis
18%
Network Structure
5%
People Who Inject Drugs
27%
Phylodynamic Analysis
5%
Phylodynamics
6%
Phylogenetic Analysis
6%
Phylogenetic Clustering
6%
Pol Gene
6%
Public Health
5%
Publicly Available
6%
Regular Screening
5%
Repeated Transmission
6%
Reverse Transcriptase
6%
Risk Environment
5%
Sexual Networks
5%
Sexually Transmitted
17%
Sexually Transmitted Infections
25%
Signature mutations
25%
Target Programs
5%
Time to the Most Recent Common Ancestor (TMRCA)
6%
Transmission Cluster
10%
Transmission Dynamics
5%
Tuberculosis
25%
Viral Phylogenetics
5%
Virus Prevalence
16%
Virus Prevention
25%
Medicine and Dentistry
Hepatitis B
25%
Hepatitis B Virus
25%
Hepatitis C
25%
High Risk Population
5%
Human Immunodeficiency Virus
75%
Human Immunodeficiency Virus Infection
9%
Infection
7%
Mixed Infection
8%
Phylogeny
8%
Prevalence
6%
Study Participant
8%